Old Systems are Creating Cybersecurity Challenges for Healthcare Orgs

device42 banner ad

 

Healthcare organizations face significant hurdles in maintaining strong and secure cybersecurity measures as tech evolves. Some of that is due to aging network infrastructures and high costs of essential software, which have created complex cybersecurity challenges. As healthcare continues to rely increasingly on digital solutions for patient care, the stakes for securing these systems against cyber threats is now an extremely great task. 

How can healthcare organizations effectively enhance their cybersecurity strategies amidst financial and technological constraints?

During an “Experts Talk” roundtable shedding light on cybersecurity in healthcare, Davy Wittock, Chief Business Officer at Flux Technologies, shared his take on the subject of cybersecurity challenges. Wittock explained some of the intricacies of healthcare cybersecurity and how organizations can navigate their limited resources and outdated systems to safeguard sensitive patient data. 

Below are several takeaways from Wittick’s comprehensive analysis:

  • Many healthcare providers operate with network infrastructure that is decades old, making it difficult to implement modern security measures effectively.
  • The financial burden of necessary medical software, such as radiology and medical record systems, significantly strains budgets, often at the expense of cybersecurity spending.
  • Despite budget constraints, healthcare IT professionals implement critical security protocols, including intrusion detection systems, to combat cyber threats.
  • IT staff must balance security needs with the operational demands of healthcare environments, sometimes facing pushback from other hospital staff or systemic workflow challenges.
  • Ongoing education on cybersecurity, such as training against phishing attacks, is crucial, yet challenges persist due to the evolving nature of cyber threats and the occasional oversight in security strategies.

Wittock acknowledged that while the road to enhanced cybersecurity in healthcare is fraught with several cybersecurity challenges, strategic adjustments and a focus on continuous education and technological updates can create stronger protections.

Article written by Alexandra Simon.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More